Daniel E. Croker

3.3k total citations
13 papers, 452 citations indexed

About

Daniel E. Croker is a scholar working on Molecular Biology, Immunology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Daniel E. Croker has authored 13 papers receiving a total of 452 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Immunology and 5 papers in Cellular and Molecular Neuroscience. Recurrent topics in Daniel E. Croker's work include Receptor Mechanisms and Signaling (6 papers), Complement system in diseases (5 papers) and Neuropeptides and Animal Physiology (5 papers). Daniel E. Croker is often cited by papers focused on Receptor Mechanisms and Signaling (6 papers), Complement system in diseases (5 papers) and Neuropeptides and Animal Physiology (5 papers). Daniel E. Croker collaborates with scholars based in Australia, United Kingdom and United States. Daniel E. Croker's co-authors include Matthew A. Cooper, Reena Halai, Richard J. Lewis, Paul F. Alewood, Geraldine Kaeslin, David P. Fairlie, Peter N. Monk, Elka Palant, Dianne Alewood and Sébastien Dutertre and has published in prestigious journals such as Journal of Biological Chemistry, Scientific Reports and Journal of Medicinal Chemistry.

In The Last Decade

Daniel E. Croker

13 papers receiving 449 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel E. Croker Australia 10 296 172 110 41 37 13 452
Magda A. M. Krajnc-Franken Netherlands 9 243 0.8× 134 0.8× 76 0.7× 49 1.2× 40 1.1× 11 787
Dimitrios N. Sidiropoulos United States 10 728 2.5× 114 0.7× 151 1.4× 98 2.4× 42 1.1× 20 888
Åke Boketoft Sweden 10 282 1.0× 124 0.7× 85 0.8× 77 1.9× 24 0.6× 17 496
Jia Duan China 13 447 1.5× 63 0.4× 213 1.9× 42 1.0× 18 0.5× 23 618
E. V. Davies United Kingdom 16 392 1.3× 247 1.4× 80 0.7× 89 2.2× 60 1.6× 32 716
Martin Kratzmeier Germany 16 363 1.2× 45 0.3× 54 0.5× 30 0.7× 74 2.0× 25 653
C S Kumar United States 16 419 1.4× 229 1.3× 133 1.2× 170 4.1× 7 0.2× 21 829
Susan A. Leonhardt United States 13 369 1.2× 218 1.3× 60 0.5× 49 1.2× 54 1.5× 15 878
Karolina Bojkowska Switzerland 11 404 1.4× 91 0.5× 37 0.3× 18 0.4× 7 0.2× 14 581
Meri Mazzoni Italy 10 307 1.0× 63 0.4× 43 0.4× 73 1.8× 12 0.3× 13 503

Countries citing papers authored by Daniel E. Croker

Since Specialization
Citations

This map shows the geographic impact of Daniel E. Croker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel E. Croker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel E. Croker more than expected).

Fields of papers citing papers by Daniel E. Croker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel E. Croker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel E. Croker. The network helps show where Daniel E. Croker may publish in the future.

Co-authorship network of co-authors of Daniel E. Croker

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel E. Croker. A scholar is included among the top collaborators of Daniel E. Croker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel E. Croker. Daniel E. Croker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Schofield, Zoe, Daniel E. Croker, Avril A. B. Robertson, et al.. (2018). Characterisation of small molecule ligands 4CMTB and 2CTAP as modulators of human FFA2 receptor signalling. Scientific Reports. 8(1). 17819–17819. 6 indexed citations
2.
Croker, Daniel E., Peter N. Monk, Reena Halai, et al.. (2016). Discovery of functionally selective C5aR2 ligands: novel modulators of C5a signalling. Immunology and Cell Biology. 94(8). 787–795. 60 indexed citations
3.
Brust, Andreas, Daniel E. Croker, Barbara Colless, et al.. (2016). Conopeptide-Derived κ-Opioid Agonists (Conorphins): Potent, Selective, and Metabolic Stable Dynorphin A Mimetics with Antinociceptive Properties. Journal of Medicinal Chemistry. 59(6). 2381–2395. 30 indexed citations
4.
Salla, Manohar, Mark S. Butler, Ruby Pelingon, et al.. (2016). Identification, Synthesis, and Biological Evaluation of the Major Human Metabolite of NLRP3 Inflammasome Inhibitor MCC950. ACS Medicinal Chemistry Letters. 7(12). 1034–1038. 40 indexed citations
5.
Halai, Reena, William J. Branchett, James B. Smadbeck, et al.. (2014). Derivation of ligands for the complement C3a receptor from the C-terminus of C5a. European Journal of Pharmacology. 745. 176–181. 14 indexed citations
6.
Croker, Daniel E., Reena Halai, Geraldine Kaeslin, et al.. (2014). C5a2 can modulate ERK1/2 signaling in macrophages via heteromer formation with C5a1 and β‐arrestin recruitment. Immunology and Cell Biology. 92(7). 631–639. 55 indexed citations
7.
Croker, Daniel E., Reena Halai, David P. Fairlie, & Matthew A. Cooper. (2013). C5a, but not C5a‐des Arg, induces upregulation of heteromer formation between complement C5a receptors C5aR and C5L2. Immunology and Cell Biology. 91(10). 625–633. 41 indexed citations
8.
Halai, Reena, Daniel E. Croker, Jacky Y. Suen, David P. Fairlie, & Matthew A. Cooper. (2012). A Comparative Study of Impedance versus Optical Label-Free Systems Relative to Labelled Assays in a Predominantly Gi Coupled GPCR (C5aR) Signalling. Biosensors. 2(3). 273–290. 11 indexed citations
9.
Croker, Daniel E., Reena Halai, David P. Fairlie, & Matthew A. Cooper. (2012). Ligand-induced dimerisation of the complement C5aR and C5L2 receptors by C5a but not C5a-des Arg. Immunobiology. 217(11). 1181–1182. 2 indexed citations
10.
Brust, Andreas, Elka Palant, Daniel E. Croker, et al.. (2009). χ-Conopeptide Pharmacophore Development: Toward a Novel Class of Norepinephrine Transporter Inhibitor (Xen2174) for Pain. Journal of Medicinal Chemistry. 52(22). 6991–7002. 70 indexed citations
11.
Dutertre, Sébastien, Daniel E. Croker, Norelle L. Daly, et al.. (2008). Conopressin-T from Conus tulipa Reveals an Antagonist Switch in Vasopressin-like Peptides. Journal of Biological Chemistry. 283(11). 7100–7108. 71 indexed citations
12.
Croker, Daniel E., Sébastien Dutertre, Paul F. Alewood, & Richard J. Lewis. (2006). Discovery and pharmacology of conopressin-T, a novel vasopressin-like peptide from Conus tulipa.. Queensland's institutional digital repository (The University of Queensland). 27. 351–351. 2 indexed citations
13.
Sharpe, Iain A., Linda Thomas, Marion Loughnan, et al.. (2003). Allosteric α1-Adrenoreceptor Antagonism by the Conopeptide ρ-TIA. Journal of Biological Chemistry. 278(36). 34451–34457. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026